Olympus Previews AU3000i™ Immunoassay System
Orlando, FL, July 26, 2005 - Olympus is previewing its new AU3000i™ automated immunoassay system at the American Association for Clinical Chemistry's 2005 Annual Meeting and Clinical Lab Expo.
The AU3000i immunoassay system is designed with the same focus on quality, reliability and efficiency that distinguish Olympus AU® chemistry systems worldwide. Throughput is fast (up to 240 tests per hour) and flexible with random access processing and STAT interrupt. Magnetic particle capture and chemiluminescent detection provide excellent sensitivity and linearity for fertility, thyroid, tumor, anemia, and cardiac panels. Key software operating steps are standardized between the AU chemistry and AU3000i systems, thereby allowing lab personnel to easily move between systems. Ease of use is enhanced by the Windows® operating system, touch screen interface, videos, color-coded graphics and integrated User's Guide.
The AU3000i will be available as a separate workstation or as a workcell with AU chemistry systems. The Olympus AU-CONNECTOR™ integrates specimen movement between two to four Olympus AU Chemistry and AU3000i systems. The workcell design supports STAT processing, single loading area for routine specimens, and single user-interface to monitor multiple instruments.
OLYMPUS SUPPORTVISION™ system will be a part of the service and support for the AU3000i. OLYMPUS SUPPORTVISION system is an Internet-based device management system for Olympus analyzers that allows real-time monitoring of instrument performance and proactive service intervention for enhanced customer support.
Olympus America Inc. anticipates that AU3000i and the AU-CONNECTOR will be available in early 2006. At the current time they are being previewed and are for research use only, not for use in diagnostic procedures.
For more information about the Olympus AU3000i immunoassay system, contact Susan M. Watanabe, Ph.D., Senior Product Manager, Olympus Diagnostic Systems Group, (800) 223-0125, ext 5686.
About Olympus Diagnostic Systems Group
Olympus Diagnostic Systems Group provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, comprehensive patient safety systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, enhance patient safety, maximize productivity, and deliver fast, reliable results.
Olympus is a precision technology leader, designing and delivering innovative solutions in healthcare and consumer electronics worldwide.
Olympus works collaboratively with its customers and its parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
- Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
- Advanced clinical and research microscopes;
- Lab automation systems, chemistry-immuno and blood bank analyzers and reagents; and
- Digital and film cameras, and digital voice recorders.
In the U. S. and Canada, Olympus serves healthcare, scientific and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers efficiently, reliably, safely, and easily achieve superior results. Olympus is the leader in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer electronics business spans North and South America. For more information, visit www.olympusamerica.com.